SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Orthofix Medical Inc. – ‘10-K’ for 12/31/15 – ‘EX-32.1’

On:  Monday, 2/29/16, at 4:13pm ET   ·   For:  12/31/15   ·   Accession #:  1564590-16-13722   ·   File #:  0-19961

Previous ‘10-K’:  ‘10-K’ on 4/29/15 for 12/31/14   ·   Next:  ‘10-K’ on 2/27/17 for 12/31/16   ·   Latest:  ‘10-K’ on 3/5/24 for 12/31/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/29/16  Orthofix Medical Inc.             10-K       12/31/15  100:15M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.33M 
 2: EX-21.1     Subsidiaries List                                   HTML     33K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     34K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     39K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     39K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
13: R1          Document and Entity Information                     HTML     60K 
14: R2          Consolidated Balance Sheets                         HTML    102K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     43K 
16: R4          Consolidated Statements of Operations and           HTML    131K 
                Comprehensive Loss                                               
17: R5          Consolidated Statements of Changes in               HTML     73K 
                Shareholders' Equity                                             
18: R6          Consolidated Statements of Changes in               HTML     36K 
                Shareholders' Equity (Parenthetical)                             
19: R7          Consolidated Statements of Cash Flows               HTML    135K 
20: R8          Description of business                             HTML     33K 
21: R9          Summary of significant accounting policies          HTML    171K 
22: R10         Inventories                                         HTML     61K 
23: R11         Property, plant and equipment                       HTML     64K 
24: R12         Patents and other intangible assets                 HTML     90K 
25: R13         Goodwill                                            HTML     53K 
26: R14         Other current liabilities                           HTML     54K 
27: R15         Long-term debt                                      HTML     45K 
28: R16         Shareholder's equity                                HTML     41K 
29: R17         Derivative instruments                              HTML     78K 
30: R18         Fair value measurements                             HTML    194K 
31: R19         Commitments                                         HTML     52K 
32: R20         Business segment information                        HTML    262K 
33: R21         Income taxes                                        HTML    304K 
34: R22         Contingencies                                       HTML     74K 
35: R23         Pensions and deferred compensation                  HTML     40K 
36: R24         Share-based compensation plans                      HTML    311K 
37: R25         Earnings per share                                  HTML     37K 
38: R26         Quarterly financial data (Unaudited)                HTML    286K 
39: R27         Summary of significant accounting policies          HTML    231K 
                (Policies)                                                       
40: R28         Summary of significant accounting policies          HTML     87K 
                (Tables)                                                         
41: R29         Inventories (Tables)                                HTML     60K 
42: R30         Property, plant and equipment (Tables)              HTML     59K 
43: R31         Patents and other intangible assets (Tables)        HTML     90K 
44: R32         Goodwill (Tables)                                   HTML     54K 
45: R33         Other current liabilities (Tables)                  HTML     53K 
46: R34         Derivative instruments (Tables)                     HTML     70K 
47: R35         Fair value measurements (Tables)                    HTML    182K 
48: R36         Commitments (Tables)                                HTML     47K 
49: R37         Business segment information (Tables)               HTML    257K 
50: R38         Income taxes (Tables)                               HTML    306K 
51: R39         Share-based compensation plans (Tables)             HTML    306K 
52: R40         Quarterly financial data (Unaudited) (Tables)       HTML    284K 
53: R41         Description of Business - Additional Information    HTML     32K 
                (Detail)                                                         
54: R42         Summary of Significant Accounting Policies -        HTML    103K 
                Additional Information (Detail)                                  
55: R43         Summary of Significant Accounting Policies -        HTML     45K 
                Schedule of Useful Lives (Detail)                                
56: R44         Summary of Significant Accounting Policies -        HTML     56K 
                Schedule of Components of Changes in Accumulated                 
                Other Comprehensive Income (Loss) (Detail)                       
57: R45         Summary of Significant Accounting Policies -        HTML     49K 
                Schedule of Components of Changes in Accumulated                 
                Other Comprehensive Income (Loss) (Parenthetical)                
                (Detail)                                                         
58: R46         Inventories - Schedule of Inventories (Detail)      HTML     46K 
59: R47         Property, Plant and Equipment - Schedule of         HTML     45K 
                Property,Plant and Equipment (Detail)                            
60: R48         Property, Plant and Equipment - Additional          HTML     38K 
                Information (Detail)                                             
61: R49         Patents and Other Intangible Assets - Schedule of   HTML     44K 
                Patents and Other Intangibles Assets (Detail)                    
62: R50         Patents and Other Intangible Assets - Additional    HTML     33K 
                Information (Detail)                                             
63: R51         Patents and Other Intangible Assets - Schedule of   HTML     46K 
                Future Amortization Expense (Detail)                             
64: R52         Goodwill - Schedule of Net Carrying Amount of       HTML     37K 
                Goodwill (Detail)                                                
65: R53         Other Current Liabilities - Summary of Other        HTML     42K 
                Current Liabilities (Detail)                                     
66: R54         Long-Term Debt - Additional Information (Detail)    HTML    106K 
67: R55         Stockholders' equity - Additional Information       HTML     40K 
                (Detail)                                                         
68: R56         Derivative Instruments - Schedule of Fair Values    HTML     40K 
                of Derivative Instruments (Detail)                               
69: R57         Derivative Instruments - Schedule of Gain (Loss)    HTML     37K 
                Recognized in Other Comprehensive Income (Loss)                  
                (Detail)                                                         
70: R58         Derivative Instruments - Additional Information     HTML     55K 
                (Detail)                                                         
71: R59         Fair Value Measurements - Schedule of Financial     HTML     65K 
                Assets and Liabilities Recorded at Fair Value on                 
                Recurring Basis (Detail)                                         
72: R60         Fair Value Measurements - Additional Information    HTML     55K 
                (Detail)                                                         
73: R61         Fair Value Measurements - Schedule of               HTML     43K 
                Reconciliation of Debt Securities (Detail)                       
74: R62         Commitments - Additional Information (Detail)       HTML     36K 
75: R63         Commitments - Schedule of Future Minimum Lease      HTML     44K 
                Payments Under Operating Leases (Detail)                         
76: R64         Business Segment Information - Additional           HTML     31K 
                Information (Detail)                                             
77: R65         Business Segment Information - Schedule of Net      HTML     52K 
                Sales by SBU Reporting Segment (Detail)                          
78: R66         Business Segment Information - Summary of Net       HTML     77K 
                Margin, Defined as Gross Profit Less Sales and                   
                Marketing Expenses from Continuing Operations by                 
                SBU Reporting Segment (Detail)                                   
79: R67         Business Segment Information - Schedule of          HTML     45K 
                Depreciation and Amortization by SBU Reporting                   
                Segment (Detail)                                                 
80: R68         Business Segment Information - Summary of Net       HTML     53K 
                Sales by Geographic Destination (Detail)                         
81: R69         Business Segment Information - Summary of           HTML     44K 
                Property, Plant and Equipment of Reporting                       
                Segments by Geographic Area (Detail)                             
82: R70         Income Taxes - Schedule of Income (Loss) from       HTML     38K 
                Continuing Operations Before Provision for Income                
                Taxes (Detail)                                                   
83: R71         Income Taxes - Schedule of Provision for (Benefit   HTML     53K 
                from) Income Taxes on Continuing Operations                      
                (Detail)                                                         
84: R72         Income Taxes - Schedule of Tax Effects of           HTML     68K 
                Significant Temporary Differences Comprising                     
                Deferred Tax Assets and Liabilities (Detail)                     
85: R73         Income Taxes - Additional Information (Detail)      HTML     45K 
86: R74         Income Taxes - Schedule of Effective Income Tax     HTML     91K 
                Rate Reconciliation for Continuing Operations                    
                (Detail)                                                         
87: R75         Income Taxes - Schedule of Gross Unrecognized Tax   HTML     39K 
                Benefits (Excluding Interest and Penalties)                      
                (Detail)                                                         
88: R76         Contingencies - Additional Information (Detail)     HTML     67K 
89: R77         Pensions and Deferred Compensation - Additional     HTML     68K 
                Information (Detail)                                             
90: R78         Share-based Compensation plans - Additional         HTML    114K 
                Information (Detail)                                             
91: R79         Share-based Compensation Plans - Schedule of        HTML     51K 
                Share-Based Compensation by Line Item in                         
                Consolidated Statements of Operations (Detail)                   
92: R80         Share-based Compensation Plans - Schedule of        HTML     46K 
                Share-based Payment Award, Valuation Assumptions                 
                (Detail)                                                         
93: R81         Share-based Compensation Plans - Schedule of Stock  HTML     68K 
                Option Activity (Detail)                                         
94: R82         Share-based Compensation Plans - Schedule of Stock  HTML     99K 
                Options Outstanding and Exercisable by Exercise                  
                Price Range (Detail)                                             
95: R83         Share-based Compensation Plans - Schedule of        HTML     58K 
                Changes in Restricted Stock (Detail)                             
96: R84         Earnings Per Share - Additional Information         HTML     48K 
                (Detail)                                                         
97: R85         Quarterly Financial Data - Condensed Consolidated   HTML     74K 
                Statement of Operations (Detail)                                 
99: XML         IDEA XML File -- Filing Summary                      XML    188K 
98: EXCEL       IDEA Workbook of Financial Reports                  XLSX    121K 
 7: EX-101.INS  XBRL Instance -- ofix-20151231                       XML   4.57M 
 9: EX-101.CAL  XBRL Calculations -- ofix-20151231_cal               XML    239K 
10: EX-101.DEF  XBRL Definitions -- ofix-20151231_def                XML    665K 
11: EX-101.LAB  XBRL Labels -- ofix-20151231_lab                     XML   1.58M 
12: EX-101.PRE  XBRL Presentations -- ofix-20151231_pre              XML   1.20M 
 8: EX-101.SCH  XBRL Schema -- ofix-20151231                         XSD    238K 
100: ZIP         XBRL Zipped Folder -- 0001564590-16-013722-xbrl      Zip    245K  


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C: 

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Orthofix International N.V. (“Orthofix”) on Form 10-K for the period ended December 31, 2015, (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, Bradley R. Mason, Chief Executive Officer and President of Orthofix, and Doug Rice, Chief Financial Officer, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Orthofix.

 

Dated: February 29, 2016

 

 

 

 

 

/s/ BRADLEY R. MASON

 

 

 

 

 

 

Name: Bradley R. Mason

 

 

 

 

 

 

Title:   President and Chief Executive Officer

 

Dated: February 29, 2016

 

 

 

 

 

/s/ DOUG RICE

 

 

 

 

 

 

Name:  Doug Rice

 

 

 

 

 

 

Title:    Chief Financial Officer

 

 

 

 

 

 

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/29/168-K
For Period end:12/31/15SD
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/16  SEC                               UPLOAD9/24/17    1:37K  Orthofix Medical Inc.
 7/13/16  SEC                               UPLOAD9/24/17    1:162K Orthofix Medical Inc.
Top
Filing Submission 0001564590-16-013722   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 10:06:05.1pm ET